partners and grants
Who supports us
The laboratory advances its projects with support from industrial partners, Russian research foundations, ministries, and international research programs.
ecosystem
Supporting organizations
Ministry of Science and Higher Education of Russia
OTCPharm
Russian Science Foundation
NADP
Italian Cystic Fibrosis Research Foundation
Russian Foundation for Basic Research
Ministry of Industry and Trade of Russia
Cystic Fibrosis Foundation
EU Seventh Framework Programme
EU Sixth Framework Programme
Industrial grants
2022-present
Development of a drug candidate for dementia associated with aging, Alzheimer's disease, depression, and multiple sclerosis
R-Pharm, Ministry of Science and Higher Education of Russia
2019-present
Design and synthesis of a new generation of direct-acting anti-influenza drugs
OTCPharm
Government and international grants
2024-2026
Fundamentals of small-molecule blockers of virus interaction with host cells
Russian Science Foundation
2021-2023
Bringing mycobacterial secretion inhibitors to maturation
Netherlands Antibiotic Development Platform, Netherlands
2021-2023
Virulence factors of Mycobacterium tuberculosis as a new target for small molecules with an original mechanism of action
Russian Science Foundation
2019-2023
New weapons against Mycobacterium abscessus and other nontuberculous mycobacteria
Italian Cystic Fibrosis Research Foundation
2021-2022
PDSTP drug candidate for prevention and treatment of SARS-CoV-2 infections
Ministry of Science and Higher Education of Russia
2021-2022
AI-based multidisciplinary platform for accelerating drug discovery and repurposing for COVID-19
Russian Foundation for Basic Research
2013-2020
Preclinical studies of a drug based on compounds blocking heparin receptors for herpesvirus infections
Pharma-2020 Strategy, Ministry of Industry and Trade of Russia
2017-2019
New generation of HIV non-nucleoside reverse transcriptase inhibitors preventing HIV-associated neurocognitive disorders
Russian Foundation for Basic Research, National Institutes of Health
2016-2018
Design, synthesis, and mechanism studies of new heterocyclic compounds active against latent tuberculosis
Ministry of Science and Higher Education of Russia
2016-2018
New inhalable compounds against the cystic fibrosis pathogen Burkholderia cenocepacia
Cystic Fibrosis Foundation, USA
2011-2016
More Medicines for Tuberculosis (MM4TB)
EU Seventh Framework Programme
2006-2010
New Medicines for Tuberculosis (NM4TB)
EU Sixth Framework Programme